Appendix 1.
Characteristics of patients aged 18–29 years diagnosed with cervical cancer identified over the study period who responded, who were interviewed versus not interviewed and patients identified over the study period versus patients aged 18–29 years diagnosed with cervical cancer in England in 2010
| Patients interviewed (N = 128), n (%) | Patients not interviewed (N = 206), n (%) | Patients diagnosed in 2010 a (N = 352), n (%) | Patients identified over study period (N = 334), n (%) | |
|---|---|---|---|---|
| Age at diagnosis, years | ||||
| 18–24 | 22 (17) | 10 (5) | 45 (13) | 32 (10) |
| 25–29 | 106 (83) | 196 (95) | 307 (87) | 302 (90) |
|
| ||||
| FIGO stage b | ||||
| 1a | 67 (52) | 127 (62) | 267 (88) | 303 (93) |
| 1b | 52 (41) | 56 (27) | ||
| 2 | 6 (5) | 12 (6) | 22 (7) | 17 (5) |
| 3 | 3 (2) | 1 (0.5) | 6 (2) | 4 (1) |
| 4 | 0 | 2 (1) | 7 (2) | 7 (2) |
| Missing | 0 | 8 (3) | 50 | 8 |
|
| ||||
| Histology | ||||
| Squamous cell carcinoma | 93 (73) | 170 (83) | 276 (78) | 263 (79) |
| Adenocarcinoma | 28 (22) | 28 (14) | 47 (13) | 56 (17) |
| Other | 7 (5) | 6 (3) | 29 (8) | 13 (4) |
| Missing | – | 2 (1) | – | 2 (1) |
|
| ||||
| Strategic Health Authority | ||||
| North East | 19 (9) | 7 (5) | 28 (8) | 26 (8) |
| North West | 35 (17) | 17 (13) | 64 (18) | 52 (16) |
| Yorkshire & Humber | 38 (18) | 24 (19) | 49 (14) | 62 (19) |
| East Midlands | 19 (9) | 14 (11) | 34 (10) | 33 (10) |
| West Midlands | 27 (13) | 15 (12) | 38 (11) | 42 (13) |
| East of England | 21 (10) | 11 (9) | 33 (9) | 32 (10) |
| London | 14 (7) | 15 (12) | 27 (8) | 26 (8) |
| South East Coast | 5 (2) | 4 (2) | 17 (5) | 20 (6) |
| South Central | 14 (7) | 7 (5) | 21 (6) | 21 (6) |
| South West | 14 (7) | 6 (5) | 41 (12) | 20 (6) |
Some percentages do not add up to 100% due to rounding.
a
Data supplied by Trent Cancer Registry from the 2010 National Cancer Data Repository.
b
For patients diagnosed in England in 2010 and patients identified over the study period, percentages were calculated using the number of patients with known FIGO stage as the denominator because of the high proportion of patients with missing stage. FIGO = International Federation of Gynecology and Obstetrics.